Position in AVTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,422,579
+$17,886,138 QoQ
Shares Held
1,105,118
+550.5% QoQ
Ownership
2.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 126 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. AVTX ranks #132 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in AVTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,422,579 | 1,105,118 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,536,441 | 169,889 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,017,319 | 166,152 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,324,241 | 104,189 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $551,194 | 110,460 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $863,573 | 107,812 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $779,057 | 104,853 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $96,054 | 10,111 | Shares | Defined | 2024-11-12 | |
| 2023-09-30 | $16,155 | 133,518 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $28,744 | 80,970 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $89,831 | 51,332 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $258,713 | 51,332 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $170,714 | 51,420 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $423,194 | 846,389 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $988,123 | 1,362,929 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,256,870 | 1,327,571 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,708,392 | 1,242,382 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 CERC | — | 1,309,958 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 CERC | — | 1,055,330 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 CERC | — | 695,001 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 CERC | — | 636,954 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 CERC | — | 368,263 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 CERC | — | 265,580 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||